Psychedelic Stocks Index Sank 15.9% On Tuesday

31 biopharmaceutical companies are now involved in the research and development of psychedelic compounds to treat mental health issues and this article tracks the performance of 15 of them in the new Psychedelic Stocks Index and names the other 16.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.